Pahlm, Ulrika
Ostenfeld, Ellen
Seemann, Felicia
Engblom, Henrik
Erlinge, David
Heiberg, Einar
Arheden, Håkan
Carlsson, Marcus http://orcid.org/0000-0002-9480-5250
Funding for this research was provided by:
Vetenskapsrådet (Vetenskapsrådet)
Hjärt-Lungfonden (Hjärt-Lungfonden)
Knut och Alice Wallenbergs Stiftelse (Wallenberg Molecular Medicine)
Philips (CHILL-MI)
Lunds Universitet (ALF)
Article History
Received: 26 February 2020
Accepted: 19 May 2020
First Online: 29 June 2020
Ethics approval and consent to participate
: Written informed consent was obtained from all subjects in the original study. The Regional Ethical Review Board in Lund, Sweden, approved the CHILL-MI study and permission from local ethical review boards was granted at each center.
: Not applicable.
: MC, EH, HE and HA received consultancy fees from Imacor AB for cardiac MRI analysis in the CHILL-MI trial. HA is stock owner of Imacor AB. EH is owner of Medviso AB producing software for cardiac image analysis.